CHINA – GlaxoSmithKline plc has unveiled the world’s first biological agent, Benlysta for the treatment of lupus nephritis at the 4th China International Import Expo. Lupus nephritis is a kidney…
Read MoreGlaxo’s biological agent offers a glimmer of hope for lupus patients
